PolyNovo Limited (PNV.AX)
AUD 1.25
(-2.35%)
AUD 1.25
(-2.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 109.16 Million AUD | 17.38% |
| 2023 | 92.62 Million AUD | 164.85% |
| 2022 | 34.97 Million AUD | -8.78% |
| 2021 | 38.33 Million AUD | 1.27% |
| 2020 | 37.85 Million AUD | 34.11% |
| 2019 | 28.22 Million AUD | -5.34% |
| 2018 | 29.82 Million AUD | 147.36% |
| 2017 | 12.05 Million AUD | -24.77% |
| 2016 | 16.02 Million AUD | 97.21% |
| 2015 | 8.12 Million AUD | -13.68% |
| 2014 | 9.41 Million AUD | 9.22% |
| 2013 | 8.61 Million AUD | -3.26% |
| 2012 | 8.9 Million AUD | -24.32% |
| 2011 | 11.77 Million AUD | -21.64% |
| 2010 | 15.02 Million AUD | -13.11% |
| 2009 | 17.28 Million AUD | 0.73% |
| 2008 | 17.16 Million AUD | -22.05% |
| 2007 | 22.01 Million AUD | -11.75% |
| 2006 | 24.94 Million AUD | 33.51% |
| 2005 | 18.68 Million AUD | 0.19% |
| 2004 | 18.65 Million AUD | 149.53% |
| 2003 | 7.47 Million AUD | -40.75% |
| 2002 | 12.61 Million AUD | 74.65% |
| 2001 | 7.22 Million AUD | -39.62% |
| 2000 | 11.96 Million AUD | 69.01% |
| 1999 | 7.07 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 109.16 Million AUD | 17.86% |
| 2024 Q4 | 109.16 Million AUD | 0.0% |
| 2024 Q2 | 97.2 Million AUD | 0.0% |
| 2023 FY | 92.62 Million AUD | 164.85% |
| 2023 Q2 | 89.23 Million AUD | 0.0% |
| 2023 Q4 | 92.62 Million AUD | 0.0% |
| 2022 Q2 | 36.59 Million AUD | 0.0% |
| 2022 Q4 | 34.97 Million AUD | 0.0% |
| 2022 FY | 34.97 Million AUD | -8.78% |
| 2021 Q4 | 38.33 Million AUD | 0.0% |
| 2021 Q2 | 36.3 Million AUD | 0.0% |
| 2021 FY | 38.33 Million AUD | 1.27% |
| 2020 Q2 | 29.58 Million AUD | 0.0% |
| 2020 FY | 37.85 Million AUD | 34.11% |
| 2020 Q4 | 37.85 Million AUD | 0.0% |
| 2019 Q4 | 28.22 Million AUD | 0.0% |
| 2019 Q2 | 28.73 Million AUD | 0.0% |
| 2019 FY | 28.22 Million AUD | -5.34% |
| 2018 Q4 | 29.82 Million AUD | 0.0% |
| 2018 FY | 29.82 Million AUD | 147.36% |
| 2018 Q2 | 32.35 Million AUD | 0.0% |
| 2017 FY | 12.05 Million AUD | -24.77% |
| 2017 Q2 | 14.56 Million AUD | 0.0% |
| 2017 Q4 | 12.05 Million AUD | 0.0% |
| 2016 FY | 16.02 Million AUD | 97.21% |
| 2016 Q2 | 18.14 Million AUD | 0.0% |
| 2016 Q4 | 16.02 Million AUD | 0.0% |
| 2015 Q2 | 8.03 Million AUD | 0.0% |
| 2015 Q4 | 8.12 Million AUD | 0.0% |
| 2015 FY | 8.12 Million AUD | -13.68% |
| 2014 Q2 | 10.56 Million AUD | 0.0% |
| 2014 FY | 9.41 Million AUD | 9.22% |
| 2014 Q4 | 9.41 Million AUD | 0.0% |
| 2013 FY | 8.61 Million AUD | -3.26% |
| 2013 Q2 | 8.09 Million AUD | 0.0% |
| 2013 Q4 | 8.61 Million AUD | 0.0% |
| 2013 Q3 | 8.61 Million AUD | 6.53% |
| 2013 Q1 | 8.09 Million AUD | -9.19% |
| 2012 Q4 | 8.9 Million AUD | 0.0% |
| 2012 FY | 8.9 Million AUD | -24.32% |
| 2011 Q4 | 11.77 Million AUD | 0.0% |
| 2011 FY | 11.77 Million AUD | -21.64% |
| 2010 Q4 | 15.02 Million AUD | 0.0% |
| 2010 FY | 15.02 Million AUD | -13.11% |
| 2009 Q4 | 17.28 Million AUD | 0.0% |
| 2009 FY | 17.28 Million AUD | 0.73% |
| 2008 Q4 | 17.16 Million AUD | 0.0% |
| 2008 FY | 17.16 Million AUD | -22.05% |
| 2007 Q4 | 22.01 Million AUD | 0.0% |
| 2007 FY | 22.01 Million AUD | -11.75% |
| 2006 FY | 24.94 Million AUD | 33.51% |
| 2006 Q4 | 24.94 Million AUD | 0.0% |
| 2005 Q4 | 18.68 Million AUD | 0.0% |
| 2005 FY | 18.68 Million AUD | 0.19% |
| 2004 Q4 | 18.65 Million AUD | 0.0% |
| 2004 FY | 18.65 Million AUD | 149.53% |
| 2003 FY | 7.47 Million AUD | -40.75% |
| 2003 Q4 | 7.47 Million AUD | 0.0% |
| 2002 FY | 12.61 Million AUD | 74.65% |
| 2002 Q4 | 12.61 Million AUD | 0.0% |
| 2001 FY | 7.22 Million AUD | -39.62% |
| 2001 Q4 | 7.22 Million AUD | 0.0% |
| 2000 FY | 11.96 Million AUD | 69.01% |
| 2000 Q4 | 11.96 Million AUD | 0.0% |
| 1999 FY | 7.07 Million AUD | 0.0% |
| 1999 Q4 | 7.07 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 9.039% |
| Adherium Limited | 9.88 Million AUD | -1004.13% |
| Aroa Biosurgery Limited | 101.82 Million AUD | -7.213% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -859.372% |
| Anteris Technologies Ltd | 45.7 Million AUD | -138.871% |
| Control Bionics Limited | 9.02 Million AUD | -1109.297% |
| CardieX Limited | 12.64 Million AUD | -762.994% |
| Compumedics Limited | 40.35 Million AUD | -170.497% |
| Cochlear Limited | 2.74 Billion AUD | 96.023% |
| CleanSpace Holdings Limited | 26.05 Million AUD | -319.039% |
| Cyclopharm Limited | 45.91 Million AUD | -137.763% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | -355.405% |
| Nova Eye Medical Limited | 29.88 Million AUD | -265.327% |
| HeraMED Limited | 2.95 Million AUD | -3597.953% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -796.572% |
| ImpediMed Limited | 46.98 Million AUD | -132.339% |
| InhaleRx Limited | 1.57 Million AUD | -6822.957% |
| LBT Innovations Limited | 7.93 Million AUD | -1276.459% |
| Micro-X Limited | 26.89 Million AUD | -305.901% |
| Neurotech International Limited | 12.21 Million AUD | -793.831% |
| OncoSil Medical Limited | 6.71 Million AUD | -1524.895% |
| Respiri Limited | 6.19 Million AUD | -1663.342% |
| SomnoMed Limited | 69.8 Million AUD | -56.389% |
| Universal Biosensors, Inc. | 30.12 Million AUD | -262.436% |
| Uscom Limited | 5.13 Million AUD | -2026.095% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -874.236% |